New chemo approach tested for aggressive breast cancer brain spread
NCT ID NCT02422641
Summary
This study tests whether high-dose methotrexate chemotherapy given through an IV can help patients with advanced breast cancer that has spread to the membranes surrounding the brain and spinal cord. Researchers want to see if this treatment helps patients live longer than 12 weeks and measures side effects and treatment costs. The trial includes adults with specific types of breast cancer that have spread to this area, with or without brain tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Comprehensive Cancer Center at Wake Forest University (CCCWFU)
RECRUITINGWinston-Salem, North Carolina, 27157, United States
Contact Email: •••••@•••••
-
Sidney Kimmel Comprehensive Cancer Center
RECRUITINGBaltimore, Maryland, 21287, United States
Contact Email: •••••@•••••
-
Siteman Cancer Center- Washington University School of Medicine in St. Louis
ACTIVE_NOT_RECRUITINGSt Louis, Missouri, 63130, United States
Conditions
Explore the condition pages connected to this study.